Rice University COVID-19 research fund awarded final grants
On May 26, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had awarded…
Disease | Life Science News | Measles | Polio | Therapeutics | Vaccine | WHO
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupted routine vaccination efforts
On May 22, 2020, COVID 19 is disrupting life-saving immunization services around the world, putting millions of children…
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
Abbott released interim clinical study data on ID NOW COVID-19 rapid test showing strong agreement to lab-based molecular PCR tests
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
Study of BioAegis’ lead product, Gelsolin, key component of NIAID strategic plan for COVID-19 research
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
ViralClear closed $108 million equity financing for development of COVID-19 broad-spectrum oral anti-viral candidate merimepodib
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
CHF Solutions publication highlighted use of ultrafiltration for fluid management in COVID-19 patients
On May 20, 2020, CHF Solutions announced a publication highlighting the use of ultrafiltration for fluid management of…
Airway Therapeutics and Celonic Group collaborated to produce AT-100 as promising new candidate for Coronavirus
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
Oxford Immunotec released T-SPOT Discovery SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2
On May 19, 2020, the University of Oxford announced the release of the T-SPOT Discovery SARS-CoV-2 test kit….
USC antibody study showed coronavirus infection more widespread in LA County than previously thought
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the NIH of Mexico and providing leronlimab…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | NIH | Therapeutics
Autism risk estimated at 3 to 5% for children whose parents have a sibling with autism
On May 18, 2020, the NIH reported that roughly 3 to 5% of children with an aunt or…
Long-acting injectable drug prevents HIV among men and transgender women
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
Quidel’s Lyra Direct SARS-CoV-2 assay received Emergency Use Authorization and CE Mark for molecular detection of COVID-19
On May 18, 2020, Quidel announced it had received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2…
CIRM board approved clinical trials targeting COVID-19 and sickle cell disease
On May 15, 2020, the California Institute for Regenerative Medicine (CIRM) board approved new clinical trials for COVID-19…
CureVac’s Optimized mRNA platform provides positive pre-clinical results at low dose for Coronavirus vaccine candidate
On May 14, 2020, CureVac announced positive pre-clinical results at a low dose for its lead vaccine candidate…
Countries begin large-scale screening for SARS-CoV-2 in sewage
On May 14, 2020,The Scientist reported that researchers from several countries including the US, Switzerland, Italy, the Netherlands,…
ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
On May 14, 2020 Abivax announced that ABX464 inhibited replication of SARS-CoV-2 in an in vitro reconstituted human…
Thermo Fisher Scientific response to COVID-19 expanded to include new serology test
On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…
Study confirmed cats can become infected with and may transmit COVID-19 to other cats
On May 13, 2020, in a study published in the New England Journal of Medicine, scientists in the…
National Research Council of Canada and CanSino Biologics announced collaboration to advance vaccine against COVID-19
On May 12, 2020, the National Research Council of Canada (NRC) announced a collaboration with CanSino Biologics to…
U.S. Dept. of Veterans Affairs accepted mask donation from South Korea to assist with COVID-19 efforts
On May 12, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had accepted a donation of…
University of British Columbia Professor Amanda Vincent was named the 2020 winner of the Indianapolis Prize
On May 12, 2020, University of British Columbia Professor Amanda Vincent, the first biologist to study seahorses in…
Hydroxychloroquine study with in-hospital patients with COVID-19 in New York State not associated with lower in-hospital mortality
On May 11, 2020, a study was published in JAMA Network that attempts to answer the question whether…
Bellerophon Therapeutics submited investigational NDA to study INOpulse inhaled nitric oxide for treatment of COVID-19
On May 11, 2020, Bellerophon Therapeutics announced the FDA accepted its Investigational New Drug (IND) application, allowing the…
Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kits
On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its…
Airway Therapeutics announced filing with NIH to evaluate AT-100 as therapy for novel Coronavirus
On May 11, 2020, Airway Therapeutics announced a filing with the Respiratory Diseases Branch of the National Institutes…
Arbutus Biopharma announced research initiative to identify novel antiviral therapies for treatment of Coronavirus infections
On May 11, 2020, Arbutus Biopharma announced the establishment of a new research initiative focused on the identification…